LBCL
Advertisement
Could Liso-cel Become a New Second-Line Standard for Relapsed/Refractory LBCL?
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 3, 2023
Chimeric antigen receptor (CAR) T-cell therapy with lisocabtagene maraleucel (liso-cel) significantly improved ...
Read More
Advertisement
Advertisement
Latest News

Seldin Award Winner Advocates Online Education

April 29, 2025

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

April 29, 2025

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

April 28, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |